Physician profile
Alison J Mitchell
NPI 1831252238
$2,163.12
in general payments reported to CMS, 2019-2025
12 companies · $487 in 2025
The $487 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $420 · 2022: $308 · 2023: $105 · 2024: $842 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $590.79 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $344.24 | 2025 | |
| Amgen INC. | $334.87 | 2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $312.98 | 2021-2022 | |
| Zoll Circulation INC | $129.16 | 2021 | |
| Genzyme Corporation | $128.55 | 2024 | |
| Ucb, INC. | $117.54 | 2024 | Cimzia |
| Astrazeneca Pharmaceuticals LP | $70.54 | 2023 | Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.00 | 2022 | |
| W. L. Gore & Associates, INC. | $34.86 | 2023 | Gore Tag Conformable Thoracic Endoprosthesis |
| Abbvie INC. | $33.73 | 2024 | |
| Gilead Sciences, INC. | $15.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.